SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-22FTAINSCHEDULE 13GShikiar Asset Management Inc Increases Stake in FTAI Aviation Ltd.MEDIUM
Shikiar Asset Management Inc has filed a Schedule 13G with the SEC, disclosing an increased stake in FTAI Aviation Ltd. The filing, dated October 22, 2025, reveals that Shikiar Asset Management now owns 159,130 Series D Cumulative Perpetual Preferred Shares, representing 6.1% of the total outstanding shares. This marks...
2025-10-22LEUSCHEDULE 13GD. E. Shaw & Co. Reports 5.2% Ownership in Centrus Energy Corp.MEDIUM
D. E. Shaw & Co., L.P., D. E. Shaw & Co., L.L.C., and David E. Shaw have reported a 5.2% beneficial ownership in Centrus Energy Corp. as of October 16, 2025. The ownership is composed of shares held by various entities managed by D. E. Shaw & Co., including D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw Oculus Portf...
2025-10-21XFORSCHEDULE 13GEmpery Asset Management's 9.99% Stake in X4 PharmaceuticalsMEDIUM
Empery Asset Management, LP, along with Ryan M. Lane and Martin D. Hoe, filed a Schedule 13G indicating a 9.99% beneficial ownership in X4 Pharmaceuticals, Inc. The ownership includes common stock and warrants exercisable into common stock, subject to a blocker that prevents the exercise of warrants if it would result ...
2025-10-21TENSCHEDULE 13GCastleKnight Entities and Aaron Weitman File Schedule 13G for Tsakos Energy Navigation LimitedMEDIUM
CastleKnight Master Fund LP, CastleKnight Fund GP LLC, CastleKnight Management LP, CastleKnight Management GP LLC, Weitman Capital LLC, and Aaron Weitman have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 7.5% of the common shares of Tsakos Energy Navigation Limited. The filing ind...
2025-10-21RKTSCHEDULE 13GSlate Path Capital LP's Significant Stake in Rocket Companies, Inc.MEDIUM
Slate Path Capital LP, along with David Greenspan, has filed a Schedule 13G indicating a significant ownership stake in Rocket Companies, Inc. As of the filing date, October 21, 2025, Slate Path Capital LP holds 19,358,000 shares of Class A common stock, representing 2.0% of the total outstanding shares. This filing is...
2025-10-21NNESCHEDULE 13GCitadel Entities' Ownership in Nano Nuclear Energy Inc.MEDIUM
The filing is a Schedule 13G submitted by Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin, collectively referred to as the Reporting Persons. The filing discloses their ownership of shares in Nano Nuc...
2025-10-21NYTSCHEDULE 13GDarsana Capital Partners LP Increases Stake in The New York Times CompanyMEDIUM
Darsana Capital Partners LP has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in The New York Times Company. As of October 21, 2025, Darsana Capital Partners LP holds 8,500,000 shares of Class A Common Stock, representing a 5.2% ownership interest. This marks an increase of 2,250,000 shares...
2025-10-21JZXNSCHEDULE 13GSchedule 13G Filing by Empery Asset Management for Jiuzi Holdings, Inc.MEDIUM
Empery Asset Management, LP, along with Ryan M. Lane and Martin D. Hoe, filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 7.45% of the Ordinary Shares of Jiuzi Holdings, Inc. The filing indicates that Empery Asset Management, LP, serves as the investment manager for the Empery Funds, which hol...
2025-10-21IVZSCHEDULE 13GMillennium Management LLC's 5.2% Stake in Invesco Ltd.MEDIUM
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G with the SEC, disclosing a 5.2% ownership stake in Invesco Ltd. The filing, dated October 20, 2025, indicates that the entities collectively own 23,154,481 shares of Invesco's common stock, valued at ...
2025-10-21IMRXSCHEDULE 13GEmpery Asset Management LP's Schedule 13G Filing for Immuneering CorpMEDIUM
Empery Asset Management, LP, along with Ryan M. Lane and Martin D. Hoe, filed a Schedule 13G with the SEC, disclosing their beneficial ownership of Class A Common Stock and warrants of Immuneering Corp. The filing indicates that Empery Asset Management, LP, as the investment manager for the Empery Funds, may be deemed ...
2025-10-21DFDVSCHEDULE 13GCitadel Advisors LLC and Affiliates File Schedule 13G for DeFi Development Corp.MEDIUM
Citadel Advisors LLC, along with its affiliates, has filed a Schedule 13G with the SEC, disclosing their ownership of shares in DeFi Development Corp. The filing indicates that Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC each beneficially own 800,000 shares, representing 2.7% of the outstandi...
2025-10-21BETRSCHEDULE 13GSchedule 13G Filing by Orange Capital Ventures, LP for Better Home & Finance Holding CoMEDIUM
Orange Capital Ventures, LP, a Delaware limited partnership, filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 5.03% of the Class A Common Stock of Better Home & Finance Holding Co. The filing indicates that the Reporting Person, Daniel Lewis, has shared voting and dispositive power over 476,283...
2025-10-21ARECSCHEDULE 13GCitadel Advisors LLC and Affiliates File Schedule 13G for American Resources CorporationMEDIUM
Citadel Advisors LLC, along with its affiliates, has filed a Schedule 13G with the SEC, disclosing their ownership of shares in American Resources Corporation. The filing, dated October 21, 2025, reveals that Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC each beneficially own 9,661,800 shares, ...
2025-10-20RDHLSCHEDULE 13GAlumni Capital LP and Affiliates File Schedule 13G for RedHill Biopharma Ltd.MEDIUM
Alumni Capital LP, along with its general partner Alumni Capital GP LLC and controlling person Ashkan Mapar, filed a Schedule 13G with the SEC regarding their beneficial ownership of American Depository Shares (ADS) of RedHill Biopharma Ltd. The filing indicates that the Reporting Persons collectively own 369,373 ADS, ...
2025-10-20RYSCHEDULE 13GRoyal Bank of Canada's Schedule 13G Filing for ATS CorporationMEDIUM
Royal Bank of Canada (RBC) filed a Schedule 13G with the SEC, disclosing its ownership of 5,152,319 shares of ATS Corporation's common stock, representing a 5.26% ownership stake. The filing indicates that RBC holds shared voting and dispositive power over these shares. The filing also includes a Power of Attorney docu...
2025-10-20ELWSSCHEDULE 13GStrategic EP, LLC and Alexander Chase Deitch's Schedule 13G Filing for Earlyworks Co., Ltd.MEDIUM
Strategic EP, LLC and Alexander Chase Deitch have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of American Depositary Shares (ADSs) representing ordinary shares of Earlyworks Co., Ltd. The filing indicates that Strategic EP, LLC holds Pre-Funded Warrants and Warrants to purchase up to 600,96...
2025-10-20ELWSSCHEDULE 13GEadwacer Holdings and Christopher Finn Report 7.3% Ownership in Earlyworks Co., Ltd.MEDIUM
Eadwacer Holdings, LLC and Christopher Finn have filed a Schedule 13G reporting a 7.3% beneficial ownership in Earlyworks Co., Ltd. The ownership includes 1,201,920 Ordinary Shares, represented by American Depositary Shares (ADSs), and warrants to purchase additional ADSs. Eadwacer Holdings holds Pre-Funded Warrants an...
2025-10-20CCCCSCHEDULE 13GPoint72 Asset Management's 9.9% Stake in C4 TherapeuticsMEDIUM
Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G to report a 9.9% beneficial ownership in C4 Therapeutics, Inc. The ownership includes 22,647,647 shares of common stock, with 14,170,000 shares issuable upon the exercise of warrants. The warrants are sub...
2025-10-20BYNDSCHEDULE 13GContext Capital Management, LLC Files Schedule 13G for Beyond Meat, Inc.MEDIUM
Context Capital Management, LLC, along with Michael S. Rosen, William D. Fertig, and Charles E. Carnegie, filed a Schedule 13G with the SEC, reporting beneficial ownership of 20,514,535 shares of Beyond Meat, Inc. common stock, representing 5.2% of the outstanding shares. The filing indicates that the shares are held b...
2025-10-20ATSSCHEDULE 13GRoyal Bank of Canada's Schedule 13G Filing for ATS CorporationMEDIUM
Royal Bank of Canada (RBC) filed a Schedule 13G with the SEC, disclosing its ownership of 5,152,319 shares of ATS Corporation's common stock, representing 5.26% of the total shares outstanding. The filing indicates that RBC has shared voting and dispositive power over these shares. The filing also includes a Power of A...
2025-10-20FDMTSCHEDULE 13GNovo Holdings A/S Increases Stake in 4D Molecular Therapeutics, Inc.MEDIUM
Novo Holdings A/S, a Danish investment firm, has increased its stake in 4D Molecular Therapeutics, Inc. (FDMT) to 6.8% ownership, representing 3,175,000 shares. This marks a significant increase of 58.75% in shares and 321.05% in value compared to previous holdings. The filing, submitted on October 20, 2025, under Sche...
2025-10-17LDISCHEDULE 13GBlackRock, Inc. Increases Stake in LOANDEPOT INC CLASS AMEDIUM
BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership in LOANDEPOT INC CLASS A. As of the effective date of October 17, 2025, BlackRock, Inc. beneficially owns 6,228,200 shares, representing 5.5% of the outstanding common stock. This marks a significant increase from previous holdings...
2025-10-17ZGSCHEDULE 13GBlackRock, Inc. Increases Stake in Zillow Group, Inc.MEDIUM
BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership in Zillow Group, Inc. As of September 30, 2025, BlackRock beneficially owns 9,391,128 shares of Zillow's Class C Stock, representing 5.1% of the total outstanding shares. This marks a significant increase from previous holdings, wi...
2025-10-17XNCRSCHEDULE 13GBiotechnology Value Fund Group's Ownership in Xencor IncMEDIUM
The filing discloses the ownership of Biotechnology Value Fund, L.P. and its affiliates in Xencor Inc. As of October 17, 2025, Biotechnology Value Fund, L.P. owns approximately 3.5% of Xencor's outstanding shares, while Biotechnology Value Fund II, L.P. owns about 2.5%. Biotechnology Value Trading Fund OS LP owns less ...
2025-10-17WAYSCHEDULE 13GBlackRock, Inc. Increases Stake in Waystar Holding CorpMEDIUM
BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Waystar Holding Corp. As of September 30, 2025, BlackRock beneficially owns 15,925,871 shares of Waystar's common stock, representing 9.1% of the total outstanding shares. This marks a significant increase from their previ...